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Abstract
Background
One root cause of the neglect of rabies is the lack of adequate diagnostic tests in the con-
text of low income countries. A rapid, performance friendly and low cost method to detect
rabies virus (RABV) in brain samples will contribute positively to surveillance and conse-
quently to accurate data reporting, which is presently missing in the majority of rabies
endemic countries.
Methodology/Principal findings
We evaluated a rapid immunodiagnostic test (RIDT) in comparison with the standard fluo-
rescent antibody test (FAT) and confirmed the detection of the viral RNA by real time
reverse transcription polymerase chain reaction (RT-qPCR). Our analysis is a multicentre
approach to validate the performance of the RIDT in both a field laboratory (N’Djamena,
Chad) and an international reference laboratory (Institut Pasteur, Paris, France). In the field
laboratory, 48 samples from dogs were tested and in the reference laboratory setting, a
total of 73 samples was tested, representing a wide diversity of RABV in terms of animal
species tested (13 different species), geographical origin of isolates with special emphasis
on Africa, and different phylogenetic clades. Under reference laboratory conditions, speci-
ficity was 93.3% and sensitivity was 95.3% compared to the gold standard FAT test. Under
field laboratory conditions, the RIDT yielded a higher reliability than the FAT test particularly
on fresh and decomposed samples. Viral RNA was later extracted directly from the test fil-
ter paper and further used successfully for sequencing and genotyping.
Conclusion/Significance
The RIDT shows excellent performance qualities both in regard to user friendliness and reli-
ability of the result. In addition, the test cassettes can be used as a vehicle to ship viral RNA
to reference laboratories for further laboratory confirmation of the diagnosis and for epide-
miological investigations using nucleotide sequencing. The potential for satisfactory use in
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remote locations is therefore very high to improve the global knowledge of rabies epidemiol-
ogy. However, we suggest some changes to the protocol, as well as careful further valida-
tion, before promotion and wider use.
Author Summary
The high fatality and burden of rabies stands in contrast to the very low performance of labo-
ratory-based surveillance in resource-challenged countries. The absence of reliable human
and animal rabies incidence data ultimately result in neglect of disease prevention and control
and the perpetuationof RABV transmission despite the existence of powerfulmanagement
tools. Rapid, easy to perform rabies diagnostic tests that do not require expensive equipment
or special storage conditions, which can be reliably performedby trained ordinary veterinary
professionals, are neededurgently for use in low income countries. Such novel methodswill
help to accurately assess the global rabies burden and are necessary to monitor rabies control
and elimination. The present study evaluates the performance and reliability of a rapid, easy
to use rabies diagnostic tool. Overall, the validated test was in high accordance with the stan-
dard referencemethod for the detection of RABV by immunofluorescencemicroscopy and
showed even higher reliability when applied in resource poor laboratory conditions. The
obtained results support the high potential for the use of this test in the field but suggest a
change of the original technical protocol and a need for wider validation.
Introduction
Rabies is a viral zoonotic encephalomyelitis transmitted to humans after exposure to infected
mammals, mainly dogs, through bites, scratches or licks on damaged skin or mucous mem-
branes. This disease still continues to represent a public health concern worldwide, with an esti-
mate of 60,000 human deaths per year, mainly in low income countries. Because of limited
control measures in many countries and a lack of governmental concern, rabies remains a
neglected tropical disease. This neglect is especially deplorable given the entirely preventable
nature of the disease through vaccination of dogs and timely adherence to post-exposure pro-
phylaxis (PEP) of exposed victims [1, 2]. In this way, human deaths due to this zoonotic disease
could be reduced by over 95% [3, 4].
Lack of surveillance represents one major element of negligence, leading to missing data on
disease incidence, imprecise estimates of the economic impact and a general underestimation
of the true worldwide burden of rabies [4, 5, 6, 7]. This means that advocacy for rabies control
cannot be supported with solid evidence and the necessity for action is not perceived at the
decisionmaker level, for instance governmental authorities [8]. Poor surveillance is primarily a
result of lack of political commitment and resource attribution for the control of rabies, and
thus a cycle of neglect perpetuates. The vicious cycle is reinforced by the disregard of disease
control in domestic dogs, which constitute negligible economic value and the fact that rabies
affects largely marginalized communities with difficult access to healthcare. Deficiencies in
basic healthcare do not only contribute to hinder access to PEP but also lead to the misdiagno-
sis of rabies in the face of other causes of encephalitis, such as cerebral malaria, as reported in
Malawi [9]. Surveillance is fundamental to accurate burden of diseasemeasures, for advocacy
of disease control and also a prerequisite for disease elimination [10, 11]. Currently, rabies is
believed to be underreported at the extent of 1:60 in humans and this rate could even be much
higher for animal rabies incidence [6].
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One possible point of leverage to break the cycle of underreportingand neglect is the rein-
forcement and simplification of diagnostic capacities and tools. Infrastructures required for the
current standard diagnostic tests are expensive, and their methodologies and interpretation need
thoroughly experiencedpersonnel. Antigen detection of RABV using the direct fluorescent anti-
body test (FAT) is theWorld Health Organization (WHO) andWorld Organisation for Animal
Health (OIE) reference test [6, 12, 13] and is routinely performed in many developed countries.
However, it is difficult to establish in developing countries because fluorescencemicroscopes are
expensive and the requiredmaintenance is demanding. Also, the immunofluorescence conjugate
necessary for the test is costly and has to be transported and stored refrigerated. Finally, accurate
reading of the test needs stringent quality control of the test performance and very experienced
personnel. Similar constraints are encountered with the direct rapid immunohistochemical test
(DRIT) [14, 15]. Although the DRIT can be read using a light microscope, the test methodology
requires a meticulous protocol which currently lacks commercialized biotinylated anti-rabies
antibodies and has to be carried out by trained personnel. For rabies diagnosis however, a simpler
field test is desirable for various reasons. In the current situation the benefits of rabies diagnosis
are not well perceived by the public and rabies suspicious animals are often killed immediately
and rapidly disposed [16]. Also, a short time lag between suspicion and confirmation of a rabies
case is important for early adherence to PEP or the cost savings in case of a negative diagnostic
result. Finally, transport of samples over long distances in climatically warm settings increases
the risk of poor sample quality, which adversely affects FAT test results [17]. Proximity to the
public through decentralized laboratory facilities is therefore vital for good sample quality, as well
as rapid detection and response.
A rapid immunodiagnostic test (RIDT) based on the lateral flow principle was first
described and evaluated in 2007 on a limited panel of RABV samples [18]. The same study
reported on the detection limit and potential risk of cross reactivity. Further laboratory evalua-
tion was conductedmore recently on the use of this RIDT for the detection of RABV circulat-
ing in Europe, and extended to the detection of other species of lyssaviruses [19, 20]. Both
studies showed positive results regarding sensitivity and specificity of such tests compared to
the FAT. To date, only two studies have been conducted under field conditions, both suggest-
ing positive results for the use of RIDT [21, 22].
In our study, we evaluated the practicability and the performance of this RDIT identified as
Anigen Rapid Rabies Test (Anigen test) (Bionote Inc.) in different settings: under field condi-
tions with its application to the surveillanceof rabid animals in N’Djamena, Chad and in labo-
ratory settings with a panel of selected RABV isolates. Lastly, we evaluated this tool for a novel
application in rabies surveillance,with its use as a vehicle for viral RNA storage and conserva-
tion, and demonstrated that recovery and detection of RNA present on the strip of positive
samples was possible. The Anigen test appears as a promising tool for the post-mortem diagno-
sis of animal rabies, and the molecular detection and genotyping of positive test strips.
Materials and Methods
Implementation of the Anigen test in the field
During June 2012, the RIDT Anigen test, a chromatographic immunoassay-based on lateral
flow technologymanufactured by BioNote, Inc (Gyeongi-do, Republic of Korea) [23], was
added into the routine diagnostic procedure of the rabies laboratory of the Institut de Recher-
che en Elevage pour le Développement (IRED) in N’Djamena, Chad. It was utilized in parallel
with the FAT test, which had been used since 2001. Rabies-suspect animals were presented to
the IRED by their owners or by the bite victim.No active surveillancewas initiated throughout
the study. However, awareness was intensified prior to the study period, duringMay 2012, by a
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poster campaign sensitizing the public in N’Djamena to seekmedical treatment after a dog bite
and to send the biting animal to the IRED in case of rabies suspicion.
Description of samples and isolates
For the validation of the Anigen test in the field, diagnostic results from June 2012 to February
2015 were included. Only samples originating from dogs were considered for inclusion accord-
ing to the manufacturer’s recommendation [23]. During the 33 months of the study period, a
total of 49 rabies -suspect dog heads were submitted to IRED for diagnostic testing. The origin
of the samples is detailed in Table 1. Most were in fresh condition on arrival and upon testing
(85%, n = 42). Five of the samples were decomposed, while in one case, the sample quality was
not noted. Only one sample was so decomposed that it was impossible to analyse and was
excluded from the study. The final sample size of field isolates at IREDwas 48 (Table 1).
The Anigen test was further validated at the National Reference Centre (NRC-R) andWHO
CollaboratingCenter for Rabies at the Institut Pasteur in Paris, France, on 73 samples selected
from the collections housed in both of these centers, from 12 different species originating from
various countries and belonging to different phylogenetic clades (S1 Table). All these samples
were previously analysed by FAT. Thirty of themwere negative and the remaining 43 were pos-
itive. The positive samples represented a large diversity of RABV. All these 73 samples were
stored at -80°C for archive before analysis.
In addition, the limit of detection of the RIDT was evaluated at NRC-R using a panel of 8
different isolates of RABV adapted and amplified on baby hamster kidney cells (BSR cells).
Viral suspensions were titrated on the same cells using 5-fold serial dilutions in cell culture
medium and expressed as fluorescent focus units per mL (FFU/mL). For the RIDT evaluation,
titrated RABV suspensions were first tested at several concentrations using the buffer available
from the RIDT kit as a diluent.
Description of the FAT methodology
The FAT, the gold standard technique for post-mortem diagnosis of rabies [12] was performed
at the NRC-R under quality assurance (accreditation ISO/IEC 17025), as previously described
[13]. In the rabies laboratory of N’Djamena, the FAT was performedwith some deviations
regarding the standard procedure: lack of positive and negative control samples inclusion,
absence of routine quality assessments, and storage of the immunofluorescent conjugate past
the expiration date. In this setting, two microscopic slides were prepared, with two brain
impressions per slide. If no viral characteristic fluorescent inclusions were observedon all four
impressions, the sample was considered negative. Doubtful results were declared positive due
to the potential fatal consequences of a false negative result for the bite victims. However, due
to some deviations regarding the standard procedure, it was not possible to consider FAT per-
formed ad IRED as the gold standard for the specificity and sensitivity analysis.
Description of the RIDT Anigen test methodology
The Anigen test is a simple and rapid diagnostic tool, presenting as an all-in-one included kit.
Once the brain is extracted, it is used without additional material and equipment except for
one dilution step requiring an additional vial of phosphate-buffered saline (PBS) prepared
according to the manufacturer’s recommendation. However, for our study, we omitted the first
dilution step, only using the vial with buffer provided by the kit to simplify the test procedure
in view of future application under realistic field conditions. The same procedure was used for
the Anigen test at NRC-R and at IRED. If it was possible to anatomically identify the regions of
the brain in a sample, the test was performedwith a small section of the brainstem
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Table 1. Description of samples tested in Chad and results obtained after FAT, RIDT and RT-qPCR on FTA papers. All specimens correspond to
original brain samples collected from dogs.
Identification Sampling date Origin Condition FAT Result RIDT Result RT-qPCR Result
342 06.06.2012 N’Djamena Fresh Neg Neg Neg
343 21.06.2012 N’Djamena Decomposed Pos Neg Neg
344 22.06.2012 N’Djamena Fresh Pos Pos Pos
345 28.06.2012 N’Djamena Fresh Pos Pos Pos
346 05.07.2012 N’Djamena Fresh Pos Pos Pos
347 13.07.2012 Koundoul Fresh Pos Pos Pos
348 20.07.2012 N’Djamena Fresh Pos Pos Pos
349 31.07.2012 N’Djamena Fresh Pos Pos Pos
350 08.08.2012 N’Djamena Fresh Pos Pos Pos
352 25.08.2012 N’Djamena Fresh Pos Pos Pos
354 29.08.2012 N’Djamena Fresh Pos Pos Pos
355 11.09.2012 N’Djamena Fresh Pos Pos Pos
356 12.09.2012 N’Djamena Fresh Pos Pos Pos
357 20.09.2012 N’Djamena Fresh Pos Pos Pos
358 25.09.2012 N’Djamena Fresh Pos Pos Pos
359 28.09.2012 unknown Fresh Pos Pos Pos
360 01.10.2012 N’Djamena Fresh Neg Neg Neg
361 26.10.2012 N’Djamena Fresh Pos Pos Pos
362 24.12.2024 unknown Unknown Pos Neg Neg
363 19.11.2012 N’Djamena Fresh Pos Pos Pos
364 03.12.2012 N’Djamena Fresh Pos Pos Pos
365 05.12.2012 N’Djamena Fresh Neg Neg Neg
366 06.12.2012 N’Djamena Fresh Pos Pos Pos
367 10.01.2013 Moundou Fresh Pos Pos Pos
368 11.01.2013 N’Djamena Fresh Pos Pos Pos
369 08.02.2013 N’Djamena Fresh Pos Pos Pos
371 25.03.2013 Koundoul Fresh Pos Pos Pos
372 29.05.2013 N’Djamena Fresh Pos Pos Pos
373 17.06.2013 Koundoul Fresh Pos Pos Pos
379 12.11.2013 N’Djamena Fresh Pos Pos Pos
380 12.12.2013 N’Djamena Fresh Neg Neg Neg
381 31.01.2014 N’Djamena Fresh Pos Pos Pos
383 16.04.2014 N’Djamena Fresh Neg Neg ND
384 29.04.2014 N’Djamena Fresh Neg Neg ND
386 29.04.2014 Guelendeng Fresh Neg Neg ND
389 28.05.2014 N’Djamena Decomposed Imp Neg Neg
390 06.06.2014 N’Djamena Fresh Neg Neg ND
392 23.06.2014 N’Djamena Decomposed Neg Neg ND
393 14.07.2014 Koundoul Fresh Neg Neg ND
394 18.08.2014 Loumia Fresh Pos Pos Pos
395 21.08.2014 Chawaye Fresh Pos Pos Pos
400 13.10.2014 N’Djamena Fresh Neg Neg ND
401 14.10.2014 N’Djamena Fresh Pos Pos Pos
403 09.12.2014 Loumia Fresh Pos Pos Pos
405 27.01.2015 N’Djamena Fresh Pos Pos Pos
406 05.02.2015 Djermaya Decomposed Pos Pos ND
(Continued )
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(approximately 0.1 g), otherwise the same amount of material was taken from different parts of
decomposed brain samples. The brain sample was mixed directly in the tube containing the
buffer with the swab, all included in the kit, for about one minute, until most of the brain mate-
rial was well dissolved and then put on to the test plate using the transfer pipette provided in
the kit. Four drops were deposited on the strip (corresponding to nearly 100 μL). The test
could be interpreted when the coloured liquid reached the top of the test and the purple indica-
tor colour had vanished from the filter paper background. As described by the manufacturer, a
positive test result was indicated by two purple lines, one in the test zone and the other in the
control zone. If a line only appeared in the control zone, the test was considered negative. In
cases where only the test line was coloured rather than the control band, the test was declared
invalid and was performed once again. The test took approximately 5 to 10 min after deposit of
sample and the interpretation was not be performed after 10 min, according to manufacturer
recommendations. Following these recommendations, the test was suitable for dog, raccoon
dog and cattle samples (animals which were used originally in the validation of the method
[18], and should be tested immediately after collection. In this study, two different batches
were used for the validation of the RIDT assay, with batches n°1801076 and n°1801111 for the
field and the laboratory validation, respectively.
Extraction of RNA from Anigen test and FTA Whatman cards
Brain impressions were performed directly on FTA Whatman cards, a support dedicated to the
storage and preservation of RNA [24]. Prior to use, the cards were stored at room temperature
in a sealed plastic bag in a dry and clean area. The samples were prepared by diluting a small
section (approximately 0.1 g) of the brain in 1 ml PBS (10%). After thoroughmixing, the brain
homogenate was loaded onto the card with a pipette until the sample indicator circle on the fil-
ter was covered. The cards were then dried 24 hours at room temperature before being put sep-
arately in transparent plastic bags for transportation.
To prepare the samples on FTA Whatman filter paper, 1 cm2 was cut-off from the area con-
taining the brain impression and incubated during 1 hour in Tri-Reagent LS (Molecular
Research Center, Cincinnati, Ohio, USA) or overnight in cell culture medium (DMEM) (Life
Technologies, Saint Aubin, France), then placed in Tri-Reagent. To obtain viral RNA directly
from the Anigen test strip, the cassettes were opened, the filter paper was removed and the area
where the sample was deposited was collected and placed into 1 mL of Tri-Reagent LS. For
both FTA and Anigen test supports, total RNA extractionwas performed as previously
described, followingmanufacturer recommendations [25].
Viral RNA detection by RT-qPCR
Viral RNA detectionwas performed using a one-step dual combine pan-lyssavirus RT-qPCR
assay recently described [26], targeting a conserved region among the polymerase. Briefly, this
assay includes a pan-RABV RT-qPCR probe-based technique, able to detect all representatives
of the broad genetic diversity of RABV, using two degenerated TaqMan probes. In parallel, a
Table 1. (Continued)
Identification Sampling date Origin Condition FAT Result RIDT Result RT-qPCR Result
407 11.02.2015 Dourbali Decomposed Pos Pos Pos
408 13.02.2015 N’Djamena Fresh Pos Pos Pos
Pos: positive, Neg: negative, Imp: impossible, ND: not done.
doi:10.1371/journal.pntd.0005010.t001
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SYBR Green RT-qPCR assay is able to detect all the other lyssaviruses tested, in addition to
RABV isolates. Both of these assays, which were optimized to a final reaction volume of 20 μL,
were performed using 5 μL of RNA template (previously diluted 1:10 in nuclease-freewater).
For each assay, appropriate controls were used. Details of the combined pan-lyssavirus RT-
qPCR assay are in S2 Table and in reference [26].
Evaluation of viral RNA extracted from Anigen test strips for genotyping
A selected panel of RNA extracts from Anigen test, which were found positive with the dual
combine RT-qPCR assay, were evaluated with RT-PCR to generate amplicons suitable for gen-
otyping by sequencing (at least 500 nt in length). Briefly, a volume of 6 μl of total RNA extrac-
tion was used for reverse transcription as previously described [25]. RNA was incubated at
65°C for 10 min with 2 μL of pd(N)6 random primers (200 μg/mL; Roche Diagnostics) and
2 μL of sterilized distilledwater and then were stored on ice. Each tube was incubated with 200
U of Superscript II RT (Invitrogen), 80 U of RNasin (Promega), and 10 nmol of each nucleo-
tide triphosphate (Eurobio), in a final volume of 30 μL for 90 min at 42°C, for reverse transcrip-
tion. Two microliters of complementary DNA (cDNA) were then amplified by PCR targeting
the nucleoprotein gene of RABV, as described in [27].
Evaluation of the Anigen test in an inter-laboratory trial
The RIDT assay was evaluated by the NRC-R in an inter-laboratory trial organized during
2015 by the European Union reference laboratory for rabies, which is located in Nancy, France
[28]. The FAT technique was also evaluated in parallel in this trial. The test panel consisted of
nine anonymous samples of freeze-driedhomogenized brains, either uninfected or infected
with various lyssavirus species. Details of this trial have been provided elsewhere [28].
Statistical analysis
Results obtained with FAT and Anigen techniques were compared using the McNemar and
Kappa statistic tests in Stata, and were analyzed to determine the intrinsic parameters of the
RIDT assay. However and conversely to the FAT technique done at the NRC-R, the immuno-
fluorescence assay performed at the IRED could not be considered as the reference technique
due to several deviations compared to the standard procedure. In case of discrepancy between
RIDT and FAT, samples were tested for RNA detectionwith RT-qPCR assay performed on
FTA Whatman cards impregnated with the brain of the corresponding sample. For the deter-
mination of the sensitivity and the specificity of RIDT, true positivity and true negativity was
defined according to the result that was shared by at least two tests among FAT, RIDT and
viral RNA detection.
Results
RIDT test processing and interpretation
For the majority of the total sample size (n = 121) tested at IRED and at NRC-R, the RIDT was
successfully performed,with the presence of a line clearly visible in the control zone after 5 to
15 min of migration once the sample was deposited (Fig 1A and 1B). For only a few samples
(n<10), the test was repeated, due to abnormal or incomplete migration (absence of the line in
the control zone). When they scored positive with RIDT, most samples exhibited a line with
strong intensity in the test zone (Fig 1B). In a few cases the test bands showed even higher
intensity than the control band. Also, for some samples tested at NRC-R, the line in the test
area was only faintly visible, despite a strong intensity of the line in the control zone (Fig 1A).
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Determination of the limit of detection of the RIDT
A total of eight titrated suspensions from different RABV adapted to cell culture was selected
to determine the limit of detection of the RIDT (Table 2). A volume of 100 μL of each of them,
diluted or not, were tested. The lowest number of fluorescent focus-forming units (FFU)
detectedwith this assay was 105 FFU, and was obtained for RABV 9704ARG and 04030PHI.
Fig 1. Examples of RIDT results. (A) Results from NRC-R, with six positive results including the two middle
cassettes (samples 93101 and 87006) demonstrating only a weak test line in the results window. (B) Results from
Chad, with one negative result (sample 18/12) and four positive results. The upper line visible in the results window
is the control (C) and the lower line represents the test (T). The presence of two lines depicts a positive result,
whereas the presence of only the upper line indicates a negative result. The test is considered as invalid when the
upper line is not visible (not shown).
doi:10.1371/journal.pntd.0005010.g001
Validation of a Rapid Rabies Diagnostic Tool
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0005010 October 5, 2016 8 / 16
Isolates 9147FRA and 9508CZK exhibited a positive signal with 106 FFU. Lastly, no positive
signal was obtained with the initial viral suspension for virus 8743THA and 9001FRA, indicat-
ing that the limit of detectionwas> 8.1 x 106 FFU and> 2.4 x 105 FFU, respectively.
Comparison results between FAT and RIDT
Seventy-three samples from NRC-R, including forty-three positive samples representing a
large diversity in term of host species, geographical location and genetic diversity (S1 and S3
Tables) were tested. Compared to the gold standard FAT, the RIDT demonstrated an accor-
dance of 95%. The specificitywas 93.3% with only two false positive results among the 30 FTA-
negative specimens, noticed for samples 150057 and 150125 which were originated from a dog
and a cat, respectively (Table 3, S1 and S3 Tables). The sensitivity of the RIDT was 95.3%, with
only two false negative results observed for isolates 9217ALL and 9312MAU, a red fox from
Germany and a dog fromMauritania, respectively (Table 3, S1 and S3 Tables).
Among the 48 samples included for evaluation at IRED only 3 were not concordant between
FAT and RIDT, yielding an accordance of 94% (Table 3). Two of the discordant samples
Table 2. Limit of detection of the RIDT using 8 different titrated rabies virus suspensions.
Virus straina Original host Location Initial virus concentration (FFU/mL)b Limit of detection (FFU)c
9147FRA Red fox France 3.1 x 107 106
CVS Lab isolate - 1.6 x 107 106
8743THA Human Thailand 8.1 x 107 > 8.1 x 106
9508CZK (SAD) Lab isolate - 5.4 x 108 107
PV Lab isolate - 4.3 x 107 106
9001FRA Dog French Guiana 2.4 x 106 > 2.4 x 105
9704ARG Bat Argentina 9.5 x 107 105
04030PHI Human Philippines 2.5 x 107 105
a CVS: Challenge virus strain, SAD: Street Alabama Dufferin, PV: Pasteur virus.
b Number of fluorescent focus-forming units (FFU) per mL.
c Number of fluorescent focus-forming units (FFU) deposited on the strip.
doi:10.1371/journal.pntd.0005010.t002
Table 3. Intrinsic parameters of the RIDT after laboratory evaluation (NRC-R), under field conditions (IRED) and when combining both conditions
(all).
FAT results
Pos Neg Imp Total
NRC-R Pos 41 2 0 43
Neg 2 28 0 30
Total 43 30 0 73
IRED Pos 34 0 0 34
RIDT results Neg 2 11 1 14
Total 36 11 1 48
All Pos 75 2 0 77
Neg 4 39 1 44
Total 79 41 1 121
doi:10.1371/journal.pntd.0005010.t003
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(samples 343 and 389) were decomposed and the quality remained unknown for the last one
(sample 362) (Table 1). The FAT was impossible to perform on one (sample 389) of the 3 and
for the two others (samples 343 and 362), the result was positive (S4 Table). For all these 3
specimens, RIDT tested negative (S4 Table). In these three cases, where RIDT and FAT did not
yield the same result, viral detection performed by RT-qPCR on the FTA Whatman card could
not detect viral RNA after multiple attempts confirming the negative RIDT result (S4 Table).
For sensitivity and specificity of RIDT and FAT under field conditions, true positivity and true
negativity was defined according to the result that was shared by at least two tests among FAT,
RIDT and viral RNA detection on the FTA Whatman card. The RIDT showed a higher speci-
ficity (100%) than the FAT (78.5%) at IRED. Accordance with the overall true test results of
the 48 samples from IREDwas 100% for RIDT and 94% for FAT.
The McNemar test showed no significant difference between the FAT and RIDT (Exact
McNemar significance probability = 0.5) on samples test at IRED and the Kappa value was
0.86, indicating excellent agreement between the tests. The exact McNemar significance proba-
bility for the comparison of FAT and RIDT performed at NRC-R was 1 and the Kappa value
was 0.89. Overall, of the 121 samples analysed at NRC-R and IRED, the McNemar significance
probability was found to be 0.45 and the Kappa value was 0.87.
Evaluation of viral RNA detection by RT-qPCR using Anigen test strips
and comparison with results obtained using FTA Whatman cards
A total of 51 samples were tested at NRC-R for viral RNA detection using RT-qPCR on the
Anigen test strip, which were previously found positive for the post-mortem diagnosis of rabies
(Table 4, S1 and S4 Tables). The FAT scored also positive for all of these specimens. Among
them, 32 originating from IREDwere used during the field evaluation of the RIDT, whereas 19
were obtained in NRC-R during the laboratory evaluation. Positive detectionwas obtained for
26 (81.2%), 18 (94.7%) and 44 (86.3%) samples from IRED, NRC-R and the two combined,
respectively (Table 4). In parallel, detection of viral RNA was also performed at NRC-R on
FTA Whatman cards for 31 samples, which were positive after analysis with both FAT and
RIDT at IRED (S4 Table). In this case, a perfect concordance (100%) was noticed. In addition,
viral RNA from 2 and 6 samples found previously negative with RIDT were not detected after
RT-qPCR analysis performed on the Anigen test strips and FTA Whatman cards, respectively
(Table 4). When compared to the FTA Whatman card, RT-qPCR performed on the Anigen
test strip exhibited a sensitivity of 80.6% (Table 5).
Evaluation of the use of viral RNA for genotyping after extraction from
Anigen test strips
A limited panel of viral RNA samples extracted from Anigen test strips, which were previously
confirmed positive by RT-qPCR, were secondarily tested for genotyping. A total of 14 samples
(4 originating from IRED and 10 from NRC-R) were analyzed, among them 13 (93%) provided
Table 4. Detection of viral RNA with RT-qPCR on Anigen test strip used in field conditions (IRED), in laboratory conditions (NRC-R) or
combined.
Detection of viral RNA by RT-qPCR on Anigen test strip performed
At IRED At NRC-R When combined
Pos Neg Total Pos Neg Total Pos Neg Total
RIDT results Pos 26 6 32 18 1 19 44 7 51
Neg 0 3 3 0 0 0 0 3 3
Total 26 9 35 18 1 19 44 10 54
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PCR amplicons (at least 500 nucleotides in length) targeting regions of the nucleoprotein gene
commonly used for genotyping after sequencing (S3 and S4 Tables). The only sample found
negative (isolate 9702IND) was weakly positive after FAT and RIDT tests, which could then
probably explain the absence of PCR amplification.
Evaluation of the RIDT Anigen test in an inter-laboratory trial
Finally, we evaluated the RIDT Anigen test in an inter-laboratory trial, in parallel of the FAT
on nine anonymous samples. The results obtained were concordant with those expected
(Table 6) [28]. In particular, we were able to detect three different RABV isolates (strains
CVS27 14–10, GS7 and DR627) constituting the panel, as well as 4 other lyssavirus species,
including Duvenhage virus (DUVV), European bat lyssavirus 1 (EBLV-1) and 2 (EBLV-2),
and Bokeloh bat lyssavirus (BBLV).
Discussion
The aim of our study was to evaluate both in the laboratory and under field conditions the
RIDT Anigen test in comparison with the FAT, to investigate the intrinsic parameters of this
rapid technique, as well as the relevance of its application in sub-Saharan Africa, a region with
the highest estimated per capita death rate due to rabies [4] but with poor data reporting situa-
tion [29].
We first investigated the limit of detection of this RIDT using serial dilutions of different
titrated suspensions of RABV. This value varied among the isolates tested but remaining rela-
tively high, ranked from 105 to 107 FFU.
We then evaluated the use of RIDT for post-mortem diagnosis of animal rabies in the labo-
ratory and under field conditions, and compared it to the FAT assay. Our results demonstrate
Table 5. Comparison results of the detection of viral RNA with RT-qPCR performed on FTA Whatman
cards and Anigen test strips.
Anigen test strip
Pos Neg Total
FTA Whatman card Pos 25 6 31
Neg 0 2 2
Total 25 8 33
doi:10.1371/journal.pntd.0005010.t005
Table 6. Evaluation of the RIDT Anigen test in NRC-R in an inter-laboratory trial.
Sample Lyssavirus speciesa Strain FAT RIDT
1 RABV CVS 27 14–10 Pos Pos
2 RABV GS7 Pos Pos
3 RABV DR627 Pos Pos
4 BBLV 127900 Pos Pos
5 DUVV DUVV 05–11 Pos Pos
6 EBLV-1 122938 Pos Pos
7 EBLV-2 EBL2 RV1787 Pos Pos
(1/30)
8 Negative - Neg Neg
9 Negative - Neg Neg
a RABV: Rabies virus, BBLV: Bokeloh bat lyssavirus, DUVV: Duvenhage virus, EBLV-1: European bat lyssavirus, EBLV-2: European bat lyssavirus 2.
doi:10.1371/journal.pntd.0005010.t006
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that the lateral flow test performs similar to the FAT. The accordance betweenRIDT and FAT
was high under both conditions (94%), with a specificity of the RIDT from 93.3% to 100%.
The sensitivity of this technique was also high in laboratory settings, with 95.3%, and
approached 100% under field conditions. Our results indicate the high potential of this test for
use in the resource challenged African context. Importantly, we show that the intrinsic perfor-
mance of RIDT under limited laboratory conditions could be higher compared to the FAT test.
Conversely to RIDT, several factors could affect negatively FAT results, including storage and
quality of the fluorescent conjugate, maintenance of the fluorescencemicroscope and experi-
ence of the reader. However, given the limited sample size, the explanatory power is not overly
strong and further evaluation is highly encouraged.
Lastly, we tested the RIDT Anigen test in parallel of the FAT technique in an international
inter-laboratory trial organized by the European Union reference laboratory for rabies, Nancy,
France and all results were found concordant.
As underlined by the results obtained under field conditions, the advantages of the immu-
nochromatographic test method are manifold. Samples can be analysed one by one proportion-
ate to the diagnostic demand. This is also true for FAT, however, the conjugate used for the
FAT can only be stored for a limited time to ensure the quality of the test. Similarly, storage for
the reagents is a cause for quality concern for the DRIT. For both DRIT and FAT, negative and
positive controls have to be included in the test procedure for standardization, which is not
needed for the RIDT [19]. Storage of the RIDT can be done at room temperature and does not
require refrigeration, as is necessary for the conjugates used for the DRIT and FAT test. The
tests used at IREDwere stored at 20°C in an air conditioned room. There are no data on the
reliability of the tests stored at temperatures at above 30°C, as would be encountered in many
tropical countries.
The FAT depends heavily on the quality of the immunofluorescent conjugate, the mainte-
nance of the fluorescent microscope and also on an experienced technician reading the micro-
scope slides. In contrast, RIDT is a very easy-to-use kit, which does not require a high level of
expertise. This technique is simple to perform and to interpret.
For the dog samples tested in Chad, the test had a specificity and sensitivity of 100%. How-
ever, we showed the utility of the Anigen test for many different wild and domestic mammalian
species. Our results confirmdata obtained from previous studies, and suggest that the spectrum
of species which could be tested with this RIDT is larger than recommended by the manufac-
turer (e.g., dogs, cattle and raccoon dogs) [19, 20, 21].
In our study, we mainly focused on RABV species. In particular, we were able to detect
RABV isolates belonging to all of the major phylogenetic clades defined previously [30], with
the exception of the Africa 3 clade, which was not been tested in our panel. However, positive
detection of isolates belonging to this clade has been already demonstrated [20]. In addition,
we were also able to detect 4 different other lyssavirus species, in addition to RABV, when eval-
uated this technique in an inter-laboratory trial. These results are concordant with those
obtained in two other previous studies using different lyssavirus species including African and
bat-related lyssaviruses (including Lagos bat virus,Mokola virus and Australian bat lyssavirus),
demonstrating that it can also be applicable for the detection of non-RABV lyssaviruses [19,
20, 31].
Several RIDT kits for RABV detectionwere evaluated using brain samples [18, 20, 21, 32,
33]. A very recent study evaluated 6 commercially available RIDT kits in parallel [34]. Sensitiv-
ity of the Anigen test in that study was observed to be unsatisfactory [34].
We modified the test procedure by omitting a dilution step and placing the brain sample
directly into the buffer vial provided by the test. The advantage of this approach is that the test
can be used with no additional material other than that provided in the kit. This change in
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methodologymight explain the better sensitivity of the test and the higher intensity of the test
band compared to other studies [19, 22, 35], because the RABV antigen level is higher without
a second dilution. Sharma et al. [35] found that the intensity of the test band decreases with
dilution.
Autolysis of samples is less a concern for sensitivity of the RIDT compared to the FAT and
PCR [17, 19, 36], which is illustrated by our results. Sample storage in glycerol was suggested to
interfere with the optimal test performance, affecting the intensity of the test line [19].
The successful detection of RABV RNA from the Anigen test strip in over 86.3% of samples
tested is a promising result and highlights the potential use of the kit as a vehicle for sample
submission for further confirmatory diagnostic or genotyping analysis. This potential has also
been reported by others [34]. However, the sensitivity was lower when compared to the use of
the FTA Whatman card, a dedicated support for storage and preservation of nucleic acids.
The price of less than 10 euros is less expensive compared to the cost of performing FAT
[19, 22], but still poses an affordability problem in developing countries.
Further validation has to be conducted with RIDT, especially if the results of this test will
guide decisionmaking for PEP. We demonstrated that the sensitivity of RIDT, even high, was
not complete compared to FAT. To avoid getting false negative results with this technique, we
suggest to confirm all negative results usingWHO and OIE reference techniques, such as FAT,
before excluding RABV infection in diagnostic samples.
An efficient diagnosis method is just part of the entire process of surveillance and control
needed to eliminate rabies, as comparable to translation of efficiencyof a vaccine, to the ulti-
mate immunity of the target population [37]. Therefore, all components of the surveillance sys-
tem, in which the test would be promoted and used, have to be strengthened in parallel [38].
Conclusions
Specificity and sensitivity of the evaluated Anigen test are only slightly reduced compared to
the known reference tests for rabies virus detection in brain samples. The results are promising
for field use, where the test could help to establish rapid preliminary diagnostic results, which
would be further confirmed usingWHO and OIE recommended tests at central laboratories.
However, we suggest important changes to the test protocol: skip the dilution step of brain
biopsy in PBS and perform the brain homogenate with the swab directly into the specimen
tube containing 1 ml of assay diluent, both provided in the kit. We also recommend to provide
a more precise sketch depicting the brain sampling method. Rapid rabies tests cannot substi-
tute for the current reference tests, but are crucial for the success of rabies surveillance systems
in developing countries. Further, we demonstrated here that the test cassettes can be used as a
vehicle to ship viral RNA to reference laboratories for further laboratory confirmation of the
diagnosis and for epidemiological investigations.
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